News Search Results
May 22, 2025, 11:27 ET Cellenkos Inc. and King Faisal Specialist Hospital & Research Centre, Sign Strategic MOU to Advance T Regulatory Cell Therapies for Unmet Diseases
Cellenkos Inc. Cellenkos is a clinical-stage biotechnology company advancing allogeneic, off-the-shelf, cord blood-derived T regulatory (Treg) cell therapies for rare inflammatory and autoimmune diseases. Cellenkos is a clinical-stage biotechnology company based in Houston, Texas, focused on developing
More news about: Cellenkos, Inc.
May 22, 2025, 11:17 ET Cellenkos Inc. and King Faisal Specialist Hospital & Research Centre, Sign Strategic MOU to Advance T Regulatory Cell Therapies for Unmet Diseases
Cellenkos Inc. Cellenkos is a clinical-stage biotechnology company advancing allogeneic, off-the-shelf, cord blood-derived T regulatory (Treg) cell therapies for rare inflammatory and autoimmune diseases. Cellenkos is a clinical-stage biotechnology company based in Houston, Texas, focused on developing
More news about: Cellenkos, Inc.
May 22, 2025, 11:00 ET Clymb Clinical Introduces TFL Viewer: A Cutting-Edge Platform for Collaborative Clinical Trial Reporting
application designed to streamline the review, feedback, and approval process for Tables, Figures, and Listings (TFLs) in clinical trials. Built for Biotechnology, Pharmaceutical, Medical Device, and CRO companies, TFL Viewer enhances collaboration, efficiency, and accuracy in clinical reporting, ensuring
More news about: Clymb Clinical
May 22, 2025, 10:30 ET Human Leukocyte Antigen (HLA) Typing for Transplant Market worth US$1.4 billion by 2030 with 6.0% CAGR | MarketsandMarkets™
F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Immucor, Inc. (US), Werfen (US), TBG Biotechnology Corporation (Taiwan), Fujirebio (Japan), Omixon Inc. (US), GenDX (Netherlands),
More news about: MarketsandMarkets
May 22, 2025, 09:00 ET Tally Health and Cenegenics Partner to Redefine Personalized Longevity Care
NEW YORK, May 22, 2025 /PRNewswire/ -- Tally Health™, a biotechnology company focused on extending healthspan through epigenetic testing and science-backed interventions, and Cenegenics, a leader in longevity
More news about: Cenegenics
May 22, 2025, 08:00 ET Syantra Inc completes new IP filings in cancer screening and treatment
medicine approach will enable new tools for both identifying when cancer is present and mitigating disease. A privately held, precision biotechnology company, Syantra has long been focused on cancer screening, particularly for breast cancer, utilizing a novel approach that leverages signals from
More news about: Syantra Inc.
May 22, 2025, 08:00 ET OncoSwab Announces Collaboration with Mayo Clinic to Advance Non-Invasive Cancer Diagnostics
SAN FRANCISCO, May 22, 2025 /PRNewswire/ -- OncoSwab, a biotechnology company focused on early detection of cancer through non-invasive molecular testing, today announced it has entered into a collaboration agreement
More news about: OncoSwab
May 22, 2025, 07:16 ET MAGic™ BioProcessing appoints Jonathan Royce to Board of Directors
seasoned C-suite leader with over 25 years of leadership experience in the life sciences sector, with a strong track record spanning industrial biotechnology, development, production, and commercial strategy. He has lead teams at organizations such as Millipore, GE Healthcare, Vironova, and Bio-Works
More news about: MAGic bioprocessing
May 22, 2025, 07:14 ET MAGic™ BioProcessing appoints Jonathan Royce to Board of Directors
seasoned C-suite leader with over 25 years of leadership experience in the life sciences sector, with a strong track record spanning industrial biotechnology, development, production, and commercial strategy. He has lead teams at organizations such as Millipore, GE Healthcare, Vironova, and Bio-Works
More news about: MAGic bioprocessing
May 22, 2025, 06:30 ET Peristaltic Pumps Market worth $2.38 billion in 2030 - Exclusive Report by MarketsandMarkets™
adaptability toward low-volume dosing applications. When precise and contamination-free fluid management is required, the pump is utilized in the biotechnology, pharmaceutical, medical device, and laboratory sectors. They are ideal for sensitive operations such as the mixing of chemicals for sampling, dosing
More news about: MarketsandMarkets
May 21, 2025, 21:27 ET AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA) Patients
May 22, 2025 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd., a clinical-stage Taiwanese biotechnology company focused on addressing unmet medical needs in dermatology, neurology, and rare diseases, today announced positive results from its Phase
More news about: AnnJi Pharmaceutical Co., Ltd.
May 21, 2025, 21:15 ET AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA) Patients
May 21, 2025 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd., a clinical-stage Taiwanese biotechnology company focused on addressing unmet medical needs in dermatology, neurology, and rare diseases, today announced positive results from its Phase
More news about: AnnJi Pharmaceutical Co., Ltd.
May 21, 2025, 16:21 ET Lilly's Kisunla (donanemab) receives marketing authorization in Australia for the treatment of early symptomatic Alzheimer's disease
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
May 21, 2025, 16:05 ET Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer
President and Corporate Controller for Charles River Laboratories, a publicly held global contract research organization for pharmaceutical and biotechnology companies, governmental agencies and leading academic institutions, with approximately 20,000 employees across 150 locations in over 20 countries
More news about: Ginkgo Bioworks
May 21, 2025, 10:48 ET RoC® Skincare Champions Empowered Aging with New Brand Initiative
Egan, Founder of Veracity Chris Mirabile, Founder & CEO of NOVOS and Member of the Longevity Biotechnology Association Florence Comite MD, CEO & Founder Comite Center for Precision Medicine & Healthy Longevity
More news about: RoC Skincare
May 21, 2025, 10:30 ET Leading Companies Launch American Alliance for Biomanufacturing (AAB) to Bolster U.S. Industrial Leadership
national security, and public health. The formation of AAB comes at a pivotal moment, with the National Security Commission on Emerging Biotechnology (NSCEB) calling for a
More news about: American Alliance for Biomanufacturing
May 21, 2025, 10:15 ET Liquid Handling System Market worth US$7.4 billion by 2030 with 8.0% CAGR | MarketsandMarkets™
liquid handling system segment dominates the market at present. The growth is driven by the widespread use of these systems in pharmaceutical and biotechnology companies, owing to their speed, accuracy, reliability, and consistent performance. By on application, the market for liquid handling
More news about: MarketsandMarkets
May 21, 2025, 09:11 ET Iovance Biotherapeutics (IOVA) Faces Investor Lawsuit Over Growth Projections Following Stock Plunge - Hagens Berman
SAN FRANCISCO, May 21, 2025 /PRNewswire/ -- Biotechnology firm Iovance Biotherapeutics, Inc. (NASSAQ: IOVA) is facing a securities class action lawsuit in the Northern District of California,
More news about: Hagens Berman Sobol Shapiro LLP
May 21, 2025, 08:30 ET BioDlink Clinches Brazil GMP Audit to Strengthen Emerging Markets Growth
therapeutic fields, builds cutting-edge biotechnology platforms such as new protein, new antibody, nucleic acid drugs, and adheres to the platform driven development model of "innovation+internationalization", At the same time, it explores the extensive application of biotechnology in the field of general health,
More news about: BioDlink Biopharm Co., Ltd.
May 21, 2025, 08:07 ET Integral Molecular Named a Top Workplace by Philadelphia Inquirer
May 21, 2025 /PRNewswire/ -- Integral Molecular, a founding member of Philadelphia's biotechnology hub, has been recognized as a 2025 Top Workplace by the Philadelphia Inquirer. This honor is based entirely on employee feedback and benchmarking
More news about: Integral Molecular
May 21, 2025, 08:00 ET China's Aphranel MagiCCrystal CaHA Filler Debuts Globally, Ushering in a New Era of Regenerative Aesthetic Medicine
safety and natural results worldwide." About Shanghai Moyom BiotechnologyShanghai Moyom Biotechnology is a national high-tech enterprise and leading developer of premium medical aesthetic solutions. Specializing in nano-medical
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
May 21, 2025, 08:00 ET ADAR1 Announces ISS Recommends Keros Therapeutics Stockholders WITHHOLD Votes from Directors Dr. Mary Ann Gray and Dr. Alpna Seth
investment manager based in Austin, Texas, focused on public and private equity investments in the life sciences and biotechnology sectors. The firm was founded in October 2018 by Dr. Daniel Schneeberger, who brings
More news about: ADAR1 Capital Management LLC
May 21, 2025, 07:55 ET RoviSys Expands North American Operations with New Offices in Arizona and Illinois
making substantial investments in the region. In addition to the booming data center sector, the region is experiencing significant growth in biotechnology, life sciences, and semiconductor manufacturing — all key industries for RoviSys. The new office enhances the company's ability to deliver specialized
More news about: RoviSys
May 21, 2025, 07:30 ET Freenome Appoints Linh H. Le as Chief Financial Officer
BRISBANE, Calif., May 21, 2025 /PRNewswire/ -- Freenome, a biotechnology company pioneering an early cancer detection platform, today announced the appointment of Linh H. Le as its new chief
More news about: Freenome Holdings, Inc.
May 21, 2025, 07:00 ET Marengo Appoints Dr. Everett Vokes to the Scientific Advisory Board While Advancing Invikafusp alfa Clinical Program in PD-1 Resistant Solid Tumors
Mass., May 21, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches to precision T cell activation, today announced the appointment of Everett E. Vokes,
More news about: Marengo Therapeutics